Navigation Links
JavaFit, Distributors of Vitamin Infused Fresh Roasted Coffee, Announces Partnership With CLR Roasters
Date:11/25/2008

of providing all types of packaging including various size bags, various size frac packs, brick packs and even will open up a can line later this year.

About JavaFit:
JavaFit is the leading brand in functional, fortified fresh roasted coffee and a leading developmental brand in ready to drink fortified coffee shakes and vitamin infused coffee with energy drink benefits. Javalution Coffee Company, a 6 year old Florida based company, owns the JavaFit brand and develops JavaFit's products via its renowned science team.

###

Read the full story at http://www.prweb.com/releases/vitamininfused/coffee/prweb1668314.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

4

GOOD

Page: 1 2

Related medicine news :

1. Medical Services International Inc. Continues to Add Distributors to Its Distribution Network
2. Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International
3. Snack Brothers Distributors to Sell New HEALTHYCAL+ Bottled Water
4. Bioponic Phytoceuticals Announces Master Distributorship With Natures Best Covering 1,000 West Coast Retailers
5. Tianyin Pharmaceutical Signs Over 60 New Distribution Agreements with 15 Regional Distributors
6. IgeaCare Systems USA, Inc. enters distribution agreement with Jenne Distributors, Inc.
7. Milestone Scientific Expands Domestic Sales Network With Addition of Three New Dental Distributors
8. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
9. Birdstep Technology Announced the Addition of the TACT Group to its Family of Distributors
10. Study shines more light on benefit of vitamin D in fighting cancer
11. Vitamin Es lack of heart benefit linked to dosage
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:PreViser Corporation and MacPractice Announce Cooperation Agreement 2Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 2Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 3Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 4Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 5Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 6Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 7Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 8Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 9Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 10Health News:Healthcare Realty Trust Announces Fourth Quarter Results 2Health News:Healthcare Realty Trust Announces Fourth Quarter Results 3Health News:Healthcare Realty Trust Announces Fourth Quarter Results 4Health News:Healthcare Realty Trust Announces Fourth Quarter Results 5Health News:Healthcare Realty Trust Announces Fourth Quarter Results 6Health News:Healthcare Realty Trust Announces Fourth Quarter Results 7Health News:Healthcare Realty Trust Announces Fourth Quarter Results 8Health News:Healthcare Realty Trust Announces Fourth Quarter Results 9Health News:Aneurysms in 2nd Generation May Not Come Early 2Health News:Technique May Let More Women Use Tamoxifen 2Health News:Technique May Let More Women Use Tamoxifen 3Health News:Calcium associated with lower risk of cancer in women 2
Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Increasing Diagnosis Rates and Growing Use of Key Agents Such as Pfizers Lyrica Will Drive Eight Percent Annual Growth in the Fibromyalgia Drug Market 51434 1Increasing Diagnosis Rates and Growing Use of Key Agents Such as Pfizers Lyrica Will Drive Eight Percent Annual Growth in the Fibromyalgia Drug Market 51434 2Increasing Diagnosis Rates and Growing Use of Key Agents Such as Pfizers Lyrica Will Drive Eight Percent Annual Growth in the Fibromyalgia Drug Market 51434 3Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders Advises Frost 26 Sullivan 51431 1Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders Advises Frost 26 Sullivan 51431 2Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders Advises Frost 26 Sullivan 51431 3Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 1Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 2Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 3Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 4Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 5